Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II-III Study Comparing Radiochemotherapy With the FOLFOX Regimen Versus Radiochemotherapy With 5FU-cisplatin (Herskovic Regimen) in First Line Treatment of Patients With Inoperable Oesophageal Cancer.

NCT00861094 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT00861094
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00861094 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II-III Study Comparing Radiochemotherapy With the FOLFOX Regimen Versus Radiochemotherapy With 5FU-cisplatin (Herskovic Regimen) in First Line Treatment of Patients With Inoperable Oesophageal Cancer.
Lead sponsor
UNICANCER
Phase
Phase 2/3
Overall status
Completed
Start date
March 31, 2008
Completion date
December 31, 2012
Enrollment
266 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer